Abstract:An efficient synthetic route to access rilpivirine hydrochloride was designed and demonstrated on a multikilogram scale. The synthetic route uses two subsequent aromatic nucleophilic substitutions, conducted under carefully optimized conditions to access the target in a 39% overall yield over four steps from (E)-3-(4-amino-3,5-dimethylphenyl)acrylonitrile hydrochloride 5. The procedures developed were demonstrated on multikilogram scale in our pilot plant, and the product was obtained with a purity of 99.6% by HPLC with no single impurity above 0.10%. The challenges associated with polymorph control and impurity control in an active pharmaceutical ingredient (API) are also discussed. Overall, our process toward Rilpivirine is shorter than most processes described and displays smooth reaction conditions. This work showcases the use of a Boc protecting group as a handle to achieve a more selective nucleophilic aromatic substitution process. It also illustrates the importance of solvent choice in process development to make the chemistry applicable on a large scale under safe conditions.

Preparation of a key intermediate en route to the anti-HIV drug lenacapavir

Preparation of a Key Intermediate En Route to the Anti-HIV Drug Lenacapavir

A new synthesis of the amine fragment: an important intermediate to the anti-HIV drug lenacapavir

Practical Synthesis of 7-Bromo-4-chloro-1H-indazol-3-amine: An Important Intermediate to Lenacapavir

Use of Lipase Catalytic Resolution in the Preparation of Ethyl (2S,5r)-5-((benzyloxy)amino)piperidine-2-carboxylate, a Key Intermediate of the Β-Lactamase Inhibitor Avibactam

An Engineered Aminotransferase for the Synthesis of a Key Chiral Intermediate of Lenacapavir

Development of a scalable synthetic route to (1R,5R)-2,2-dimethoxybicyclo[3.1.0]hexan-3-one: an important intermediate in the synthesis of lenacapavir

Improved Synthesis of 2‐Chloro‐3‐amino‐4‐methylpyridine

Weinreb Amide Approach To The Practical Synthesis Of A Key Remdesivir Intermediate

Rh(iii)-Catalyzed Diastereoselective Transfer Hydrogenation: an Efficient Entry to Key Intermediates of HIV Protease Inhibitors

Preparation of the Key Dolutegravir Intermediate via MgBr2-Promoted Cyclization

Synthesis of 4-Azido-4-deoxy-neu5,7,8,9ac(4)2en1me. A Key Intermediate for the Synthesis of Gg167 from D-Glucono-Delta-Lactone

An Efficient Synthesis of the Bicyclic Darunavir Side Chain Using Chemoenzymatic Catalysis

Synthesis of a Long Acting HIV Protease Inhibitor Via Metal or Enzymatic Reduction of the Appropriate Chloro Ketone and Selective Zinc Enolate Condensation with an Amino Epoxide

Preparation of the Key Dolutegravir Intermediate via MgBr<sub>2</sub>-Promoted Cyclization

Process Development of a Novel Route to Rilpivirine Hydrochloride

Development of a Cost-Efficient Process Toward a Key Synthetic Intermediate of the EZH2 Inhibitor PF-06821497

Synthesis of (2S, 3S)-1,2-epoxy-3-(Boc-amino)-4-phenylbutane

Rhodium-Catalyzed Asymmetric Transfer Hydrogenation of Heterocyclic Diaryl Ketones: Facile Access to Key Intermediate of Baloxavir

Efficient Synthesis of the C1-C7 Fragment of Didemnaketal A